| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
5,393 |
4,423 |
$403K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,295 |
2,011 |
$290K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,413 |
1,348 |
$140K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,714 |
2,362 |
$137K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
381 |
303 |
$48K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,143 |
1,890 |
$45K |
| 80053 |
Comprehensive metabolic panel |
636 |
558 |
$30K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
335 |
311 |
$29K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
14 |
14 |
$25K |
| 86140 |
|
532 |
472 |
$15K |
| 36415 |
Collection of venous blood by venipuncture |
1,313 |
1,048 |
$15K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
260 |
250 |
$9K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
178 |
173 |
$9K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
163 |
159 |
$8K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
123 |
102 |
$7K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
272 |
241 |
$7K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
216 |
205 |
$6K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
14 |
13 |
$5K |
| 87081 |
|
136 |
123 |
$3K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
24 |
24 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
53 |
48 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
14 |
12 |
$2K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
28 |
25 |
$2K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
43 |
38 |
$1K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
13 |
12 |
$1K |
| 83605 |
|
46 |
36 |
$1K |
| 84443 |
Thyroid stimulating hormone (TSH) |
12 |
12 |
$686.41 |
| 71046 |
Radiologic examination, chest; 2 views |
22 |
13 |
$685.62 |
| 82150 |
|
12 |
12 |
$409.38 |
| 81003 |
|
43 |
40 |
$398.07 |
| 71045 |
Radiologic examination, chest; single view |
25 |
12 |
$320.58 |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
37 |
37 |
$317.72 |
| 87275 |
|
12 |
12 |
$278.99 |
| 87276 |
|
12 |
12 |
$278.99 |
| 81001 |
|
13 |
12 |
$267.65 |